<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.7: Post-Viral Syndromes and Molecular Mimicry</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/PURPLE theme for Specialty Applications */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #1e3a8a;
            font-weight: 700;
            border-bottom: 2px solid #3b82f6;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box .alert-label {
            font-weight: 600;
            margin: 0 0 12px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.info {
            background: #e3f2fd;
            border-left-color: #2196f3;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f1f5f9;
            padding: 15px;
            color: #1e3a8a;
            font-weight: 600;
            border-bottom: 2px solid #e2e8f0;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f8f0;
            border-radius: 8px;
            color: #2e7d32;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
            border: 1px solid #e2e8f0;
        }

        .takeaways-box .box-label {
            font-weight: 700;
            color: #1e3a8a;
            margin-bottom: 15px;
            display: block;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            margin-top: 50px;
            font-size: 14px;
            color: #666;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            margin-top: 40px;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 7: Post-Viral Syndromes and Molecular Mimicry</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üéì Advanced Certification Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Post-Viral Landscape</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Molecular Mimicry Mechanisms</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Bystander Activation & Persistence</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Applying the C.A.L.M. Protocol</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Mitochondrial Recovery & PEM</a></li>
                <li><a href="#section6"><span class="section-num">6</span>MCAS & Cytokine Containment</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Differentiate between acute infection, viral persistence, and post-viral autoimmunity.</li>
                <li>Explain the biochemical mechanism of <span class="highlight">molecular mimicry</span> and its role in tissue-specific destruction.</li>
                <li>Analyze the intersection of Long-COVID, ME/CFS, and reactivated pathogens like EBV.</li>
                <li>Implement specific "Containment" strategies for Mast Cell Activation Syndrome (MCAS).</li>
                <li>Design lifestyle interventions for managing Post-Exertional Malaise (PEM) through strategic pacing.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Post-Viral Landscape: A New Epidemic</h2>
        <p>In the wake of the global SARS-CoV-2 pandemic, the clinical landscape of autoimmunity has shifted dramatically. While we have long understood that viruses act as primary triggers for autoimmune disease‚Äîas discussed in <span class="highlight">Module 2, Lesson 4 (Stealth Pathogens)</span>‚Äîthe sheer volume of post-viral sequelae currently presenting in clinical practice is unprecedented.</p>

        <p>A 2023 meta-analysis published in <i>Nature Reviews Microbiology</i> found that <span class="stat-highlight">at least 10% of SARS-CoV-2 infections</span> result in Long-COVID, with over 200 symptoms identified across multiple organ systems. Many of these symptoms mirror established autoimmune conditions, including Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Dysautonomia (POTS), and Small Fiber Neuropathy.</p>

        <div class="alert-box info">
            <p class="alert-label">The Specialist's Perspective</p>
            <p>As an Autoimmune Specialist, you must view a "post-viral syndrome" not as a single diagnosis, but as a complex failure of immune homeostasis where the body has failed to return to the "Ground State" after an inflammatory event.</p>
        </div>

        <h2 id="section2">2. Molecular Mimicry: The Identity Theft of Pathogens</h2>
        <p>Molecular mimicry is the primary mechanism by which a transient infection transforms into a lifelong autoimmune condition. It occurs when a foreign antigen (viral protein) shares structural similarities with self-antigens (human tissue). When the immune system mounts a defense against the virus, the <span class="highlight">B-cells and T-cells</span> "cross-react" with the host's own tissues.</p>

        <h3>The "Lock and Key" Failure</h3>
        <p>Imagine the immune system as a security guard with a photo of a criminal (the virus). If the criminal is wearing a uniform nearly identical to the staff (human proteins), the guard may begin attacking the staff. In the case of SARS-CoV-2, researchers have identified significant mimicry between the spike protein and human proteins such as <span class="highlight">Thyroid Peroxidase (TPO)</span> and Myelin Basic Protein.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Pathogen</th>
                        <th>Target Human Tissue</th>
                        <th>Associated Condition</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td>Epstein-Barr Virus (EBV)</td>
                        <td>Myelin Basic Protein / Synovial tissue</td>
                        <td>Multiple Sclerosis / Rheumatoid Arthritis</td>
                    </tr>
                    <tr>
                        <td>SARS-CoV-2</td>
                        <td>ACE2 Receptors / Mitochondria / Thyroid</td>
                        <td>Long-COVID / Hashimoto's / POTS</td>
                    </tr>
                    <tr>
                        <td>Coxsackie B Virus</td>
                        <td>Islet Cells (Pancreas)</td>
                        <td>Type 1 Diabetes</td>
                    </tr>
                    <tr>
                        <td>Campylobacter jejuni</td>
                        <td>Gangliosides (Nerve tissue)</td>
                        <td>Guillain-Barr√© Syndrome</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Bystander Activation and Viral Persistence</h2>
        <p>While mimicry is about identity, <span class="highlight">bystander activation</span> is about the environment. During an intense acute infection, the massive release of cytokines and proteolytic enzymes creates a "toxic soup" that damages healthy neighboring cells. This damage exposes intracellular components (like nuclear DNA) that the immune system usually never sees, leading to the development of <span class="highlight">Antinuclear Antibodies (ANA)</span>.</p>

        <h3>The Role of Viral Persistence</h3>
        <p>A critical question in "A" (Address Root Causes) of the C.A.L.M. Protocol is whether the virus is truly gone. We now recognize two forms of persistence:</p>
        <ul>
            <li><strong>Viral Reservoirs:</strong> Fragments of the virus (RNA or protein) remain in the gut or neurological tissue, causing chronic low-grade "C" (Containment) failures.</li>
            <li><strong>Pathogen Reactivation:</strong> The stress of a new infection (like COVID-19) allows old, latent viruses like <span class="highlight">EBV or HHV-6</span> to reactivate, further burdening the immune system.</li>
        </ul>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: Post-Viral Reactivation</p>
                    <p class="subtitle">Client: Sarah, 42 | Presenting: Severe Fatigue & Brain Fog</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-info">
                        <p><strong>History:</strong> Sarah was high-functioning until a "mild" viral infection in 2022. Since then, she experiences "crashes" after minimal activity, joint pain, and "internal tremors."</p>
                    </div>
                </div>
                <p><strong>Assessment:</strong> Lab work revealed elevated EBV Early Antigen (EA) titers (>140 U/mL) and high ANA (1:320, speckled pattern), suggesting the recent infection reactivated her latent EBV and triggered a systemic autoimmune response.</p>
                <p><strong>Intervention:</strong> Applied the C.A.L.M. Protocol focusing on <i>Containment</i> of the cytokine storm using high-dose polyphenols (Quercetin/Luteolin) and <i>Addressing</i> the viral load with monolaurin and mitochondrial support.</p>
                <p><strong>Outcome:</strong> After 4 months, Sarah reported a 70% reduction in fatigue and successfully reintroduced light walking without Post-Exertional Malaise (PEM).</p>
            </div>
        </div>

        <h2 id="section4">4. Applying the C.A.L.M. Protocol to Post-Viral Syndromes</h2>
        <p>Standard autoimmune protocols often fail post-viral clients because they focus too heavily on elimination diets without addressing the unique <span class="highlight">bioenergetic failure</span> of these conditions.</p>

        <h3>C: Contain Inflammation (The MCAS Connection)</h3>
        <p>Many post-viral clients suffer from <strong>Mast Cell Activation Syndrome (MCAS)</strong>. Their mast cells are "hyper-sensitized," releasing histamine, prostaglandins, and cytokines in response to non-threatening triggers (heat, vibration, smell). Containment here requires more than just the AIP diet; it requires a low-histamine approach and mast cell stabilizers.</p>

        <h3>A: Address Root Causes (Mitochondrial Dysfunction)</h3>
        <p>In post-viral states, the mitochondria often enter the <strong>Cell Danger Response (CDR)</strong>. This is a primitive defense mechanism where the cell stops producing energy (ATP) and focuses on hardening its membranes to prevent viral replication. If the "danger" signal is never turned off, the client remains in a state of permanent fatigue.</p>

        <h2 id="section5">5. Mitochondrial Recovery and the Pacing Paradox</h2>
        <p>In <span class="highlight">Module 3 (Lifestyle Medicine)</span>, we discussed exercise prescription. However, in post-viral syndromes, traditional exercise can be <i>dangerous</i>. This is due to <strong>Post-Exertional Malaise (PEM)</strong>‚Äîa worsening of symptoms that occurs 12‚Äì48 hours after physical or mental exertion.</p>

        <div class="alert-box warning">
            <p class="alert-label">Critical Practice Note: Pacing</p>
            <p>For clients with ME/CFS or Long-COVID, "pushing through" the fatigue causes physiological damage. You must teach <strong>Pacing</strong>: staying within the "Energy Envelope." A 2022 study showed that heart rate monitoring to stay below the ventilatory threshold is more effective than any pharmaceutical intervention for these clients.</p>
        </div>

        <h3>The Bioenergetic Support Stack</h3>
        <p>When "Addressing" the mitochondria, the goal is to provide the cofactors needed to restart the Krebs Cycle:</p>
        <ul>
            <li><strong>CoQ10 (Ubiquinol):</strong> <span class="stat-highlight">200-400mg daily</span> to support the electron transport chain.</li>
            <li><strong>D-Ribose:</strong> To bypass stalled glycolysis and provide immediate ATP substrate.</li>
            <li><strong>NAD+ Precursors:</strong> To restore the NAD+/NADH ratio, often depleted by viral PARP activation.</li>
            <li><strong>Acetyl-L-Carnitine:</strong> To facilitate the transport of fatty acids into the mitochondria for fuel.</li>
        </ul>

        <h2 id="section6">6. MCAS & Cytokine Containment Strategies</h2>
        <p>The "Cytokine Storm" isn't just an acute event; in post-viral autoimmunity, it can become a "Cytokine Drizzle"‚Äîa chronic, low-grade inflammatory state. This often presents as "brain fog" (neuroinflammation).</p>

        <div class="principle-card">
            <div class="principle-title">The Neuro-Containment Strategy</div>
            <p class="principle-text">To cross the blood-brain barrier and contain post-viral neuroinflammation, the Specialist should prioritize:</p>
            <ul>
                <li><strong>Luteolin & Apigenin:</strong> Flavonoids that specifically inhibit microglial activation.</li>
                <li><strong>Vagus Nerve Stimulation:</strong> Using the "M" (Maintain) phase techniques from Module 4 to activate the cholinergic anti-inflammatory pathway.</li>
                <li><strong>Low-Histamine AIP:</strong> Removing fermented foods, aged meats, and nightshades to reduce the total histamine load on sensitized mast cells.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <p class="box-subtitle">Test your mastery of post-viral mechanisms.</p>

            <div class="question-item">
                <p class="question-text">1. How does Molecular Mimicry differ from Bystander Activation?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Molecular Mimicry is based on structural similarity (identity) between a virus and a human protein, leading to cross-reactivity. Bystander Activation is based on collateral damage to healthy tissue during an inflammatory response, which then exposes "self" antigens to the immune system.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. Why is "Graded Exercise Therapy" (GET) contraindicated for clients with Post-Exertional Malaise (PEM)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">In PEM, the mitochondria are in a "Cell Danger Response" and cannot meet the metabolic demands of exercise. Forcing exertion leads to further cellular damage, cytokine spikes, and a potential long-term "crash" or relapse of symptoms.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways for the Specialist</p>
            <ul>
                <li>Post-viral syndromes are often a combination of <strong>molecular mimicry</strong>, <strong>bystander activation</strong>, and <strong>viral persistence</strong>.</li>
                <li>SARS-CoV-2 and EBV are major drivers of modern autoimmune flares and new-onset conditions like POTS and Hashimoto's.</li>
                <li>Mitochondrial support (CoQ10, NAD+) is a mandatory "A" (Address) intervention for post-viral fatigue.</li>
                <li><strong>Pacing</strong> is the most critical "L" (Lifestyle) tool; help clients identify their "Energy Envelope" to avoid PEM.</li>
                <li>Always screen for <strong>MCAS</strong> symptoms (hives, flushing, sudden food sensitivities) as part of the "C" (Contain) phase.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Davis, H. E., et al. (2023). "Long COVID: major findings, mechanisms and recommendations." <i>Nature Reviews Microbiology</i>.</li>
                <li>Kanduc, D., & Shoenfeld, Y. (2020). "Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine." <i>Immunologic Research</i>.</li>
                <li>Naviaux, R. K. (2019). "Perspective: Cell danger response (CDR) and its role in chronic disease." <i>Mitochondrion</i>.</li>
                <li>Prusty, B. K., et al. (2022). "Active HHV-6 infection and its role in ME/CFS and Long COVID." <i>Journal of Medical Virology</i>.</li>
                <li>Theoharides, T. C., et al. (2021). "Mast cells and glial cells in neuroinflammation and fatigue." <i>Journal of Neuroinflammation</i>.</li>
                <li>Wirth, K., & Scheibenbogen, C. (2021). "Pathophysiology of skeletal muscle disturbances in ME/CFS." <i>Journal of Translational Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>